Yeah ya got me how time flies lol
Correction
Sovaldi approved December 2013
Olysio approved November 2013
Also should have been pill not poll
Oops, I meant for Nov & Dec for Sovaldi and aolysio. The Oct (Harvoni was Oct 2014.
Lynn, wasn't that supposed to say 2013. Pat
Sovaldi was approved as a treatment with interferon and Ribavirin Dec 2014. Olysio with interferon and Ribavirin was approved Nov 2014. Per the AASLD (American Assn to the Study of Liver Diseases) guidlines Sovaldi and Olysio used together was the recommended treatment for Genotype 1 patients even though the usage at that time was "off label" meaning not per the prescribing information. Sovaldi and Olysio are two separate pills.
Harvoni was just approved by the FDA Oct 2014. Is is a single poll combo of Sovaldi and Ledipasvir. This is the same med Sovaldi but a different second drug Ledipasvir.
Simeprevir (Olysio) is a NS3/4A hepatitis C virus (HCV) protease inhibitor. While Ledipasvir is a potent inhibitor of HCV NS5A, a viral phosphoprotein that plays an important role in viral replication, assembly, and secretion. These drugs do not work in the same way as each other they are not the same class of drug.
Hope that helps
I am not familiar with the drug Olysio/Sovaldi combo. Is this similar to Harvoni???
I have had minor headaches post treatment--but no migraines. I drink a large combination of water/gatorade when this happens and that seems to help a bit.
Or that you had no viral load at week 12 of treatment?
Thanks.
Hector